Literature DB >> 23851972

Patients' experiences of participating in a large-scale trial of cognitive behavioural therapy for depression: a mixed methods study.

Bethany Simmonds1, Nicholas Turner, Laura Thomas, John Campbell, Glyn Lewis, Nicola Wiles, Katrina Turner.   

Abstract

BACKGROUND: Adequate recruitment and retention rates are vital to achieving a successful randomized controlled trial. Historically this has been particularly challenging in mental health research. Few researchers have explored patients' reasons for taking part and remaining in a depression trial.
OBJECTIVE: To explore patients' reasons for taking part and remaining in a trial that aimed to assess the effectiveness of cognitive behavioural therapy (CBT) as an adjunct to usual care for primary care patients with treatment resistant depression.
METHOD: (i)
DESIGN: Patients completed a short exit questionnaire about their experiences of taking part in the CoBalT trial. In addition, 40 semi-structured telephone interviews were conducted with a purposive sample of these patients to further explore their experiences. (ii)
SETTING: General practices, England and Scotland.
RESULTS: Of 469 patients randomized into the trial, 302 (64.4%) completed an exit questionnaire. The most frequently rated reason for taking part in the study were 'I was willing to try anything that might help me feel better' (66%). Patients indicated in interviews why they preferred follow-up data to be collected on a face-to-face basis rather than over the telephone. Some patients reported that taking part in the trial gave them a sense of self-worth and accomplishment.
CONCLUSION: Patients felt they benefited from being in the trial because it enabled them to reflect on their feelings. For some, taking part increased their feelings of self-worth. These findings may be applicable to trials where feelings of inclusion and being valued are likely to promote continued participation.

Entities:  

Keywords:  Antidepressant medication; cognitive behavioural therapy; depression; mental health; mixed methods; mood disorder; patient adherence; primary care.

Mesh:

Year:  2013        PMID: 23851972     DOI: 10.1093/fampra/cmt028

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  6 in total

1.  Analysis of Clinical Trial Exit Interview Data in Patients with Treatment-Resistant Depression.

Authors:  Sandy Lewis; Carla Romano; Geert De Bruecker; James W Murrough; Richard Shelton; Jaskaran B Singh; Carol Jamieson
Journal:  Patient       Date:  2019-10       Impact factor: 3.883

2.  The Preference for Internet-Based Psychological Interventions by Individuals Without Past or Current Use of Mental Health Treatment Delivered Online: A Survey Study With Mixed-Methods Analysis.

Authors:  Emma Emmett Karolina Wallin; Susanne Mattsson; Erik Martin Gustaf Olsson
Journal:  JMIR Ment Health       Date:  2016-06-14

3.  How can we successfully recruit depressed people? Lessons learned in recruiting depressed participants to a multi-site trial of a brief depression intervention (the 'CLASSIC' trial).

Authors:  June S L Brown; Caroline Murphy; Joanna Kelly; Kimberley Goldsmith
Journal:  Trials       Date:  2019-02-13       Impact factor: 2.279

Review 4.  Psychological therapies for treatment-resistant depression in adults.

Authors:  Sharea Ijaz; Philippa Davies; Catherine J Williams; David Kessler; Glyn Lewis; Nicola Wiles
Journal:  Cochrane Database Syst Rev       Date:  2018-05-14

5.  Understanding involvement in surgical orthopaedic randomized controlled trials: A qualitative study of patient and health professional views and experiences.

Authors:  Jeremy Horwood; Emma Johnson; Rachael Gooberman-Hill
Journal:  Int J Orthop Trauma Nurs       Date:  2015-05-14

6.  Developing an online, searchable database to systematically map and organise current literature on retention research (ORRCA2).

Authors:  Anna Kearney; Polly-Anna Ashford; Laura Butlin; Thomas Conway; William J Cragg; Declan Devane; Heidi Gardner; Daisy M Gaunt; Katie Gillies; Nicola L Harman; Andrew Hunter; Athene J Lane; Catherine McWilliams; Louise Murphy; Carrie O'Nions; Edward N Stanhope; Akke Vellinga; Paula R Williamson; Carrol Gamble
Journal:  Clin Trials       Date:  2021-10-24       Impact factor: 2.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.